Topoisomerase III-beta protects from immune dysregulation and tumorigenesis
Year: 2025
Type: article
Language: en
Topic: Cancer therapeutics and mechanisms
Authors and affiliations:
raw_author_name: Md Rasel Al Mahmud
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Simone Andrea Baechler
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Anjali Dhall
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Sourav Saha
raw_affiliation_strings: Department of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Hongliang Zhang
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Laura Bassel
raw_affiliation_strings: Molecular Histopathology Laboratory (MHL), Laboratory Animal Science Program (LASP), Frederick National Laboratory for Cancer Research, NIH, Frederick, MD 21702, USA
raw_author_name: Shuling Zhang
raw_affiliation_strings: Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
raw_author_name: Min-Jung Lee
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Nahoko Sato
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Shraddha Rastogi
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Suresh Kumar
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Muhammad S. Alam
raw_affiliation_strings: Clinical Translation Unit, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
raw_author_name: Liton Kumar Saha
raw_affiliation_strings: Department of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Beverly A. Mock
raw_affiliation_strings: Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
raw_author_name: Valentina M. Factor
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
raw_author_name: Yves Pommier
raw_affiliation_strings: Developmental Therapeutics Branch &amp; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA